Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[bhp1rtp]

NEW TOBACCO DERIVED SUPPLEMENT THAT REDUCES HASHIMOTO'S ANTIBODIES

http://www.thyroidpharmacist.com/1/post/2013/11/new-tobacco-derived-supplement-that-reduces-hashimotos-antibodies.html

As the author reviews the clinical trial Anatabloc in Thyroid Health-ASAP the author says

“ Additionally, while this was not shared in the study results, the manufacturer did share some preliminary results on TPO levels last January on their healthcare professional portal. One patient who was studied had an enormous drop in antibody levels after she took a dose of 0.12 mg/kg per day of anatabine for sixteen days. Her TPO antibodies reduced from 3655 IU to 300 IU. “